Rockefeller Capital Management
CPRX

Rockefeller Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Rockefeller Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Sell
19,712
-9,968
-34% -$237K ﹤0.01% 1992
2025
Q4 		$693K Buy
29,680
+6,752
+29% +$150K ﹤0.01% 1731
2025
Q3 		$452K Buy
22,928
+9,320
+68% +$192K ﹤0.01% 1819
2025
Q2 		$295K Buy
13,608
+3,239
+31% +$76.5K ﹤0.01% 1655
2025
Q1 		$251K Sell
10,369
-2,147
-17% -$48.3K ﹤0.01% 1619
2024
Q4 		$261K Buy
12,516
+45
+0.4% +$967 ﹤0.01% 1617
2024
Q3 		$248K Sell
12,471
-892
-7% -$16.5K ﹤0.01% 1575
2024
Q2 		$207K Buy
13,363
+357
+3% +$5.56K ﹤0.01% 1618
2024
Q1 		$207K Sell
13,006
-3,056
-19% -$46.1K ﹤0.01% 1657
2023
Q4 		$270K Buy
+16,062
New +$220K ﹤0.01% 1482
2023
Q3 		– Sell
-14,688
Closed -$125K – 1548
2023
Q2 		$125K Sell
14,688
-1,319
-8% -$19K ﹤0.01% 1748
2023
Q1 		$265K Buy
16,007
+15,707
+5,236% +$259K ﹤0.01% 1655
2022
Q4 		$5K Sell
300
-100
-25% -$1.54K ﹤0.01% 3315
2022
Q3 		$5K Sell
400
-200
-33% -$2.37K ﹤0.01% 3323
2022
Q2 		$4K Hold
600
– – ﹤0.01% 3518
2022
Q1 		$4K Hold
600
– – ﹤0.01% 3395
2021
Q4 		$4K Hold
600
– – ﹤0.01% 3334
2021
Q3 		$3K Hold
600
– – ﹤0.01% 3322
2021
Q2 		$3K Hold
600
– – ﹤0.01% 3146
2021
Q1 		$2K Hold
600
– – ﹤0.01% 3090
2020
Q4 		$2K Buy
+600
New +$2.02K ﹤0.01% 2622

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Rockefeller Capital Management's CPRX Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Catalyst Pharmaceutical (CPRX) stake by 34% in Q1 2026, selling an estimated $237K and leaving 19,712 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #1992.

Rockefeller Capital Management first reported a position in CPRX in Q4 2020 and has held it in 21 quarters since. The position peaked at $693K in Q4 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Rockefeller Capital Management held 19,712 shares of Catalyst Pharmaceutical worth $488K as of Q1 2026.
  • Rockefeller Capital Management sold 9,968 Catalyst Pharmaceutical shares in Q1 2026, an estimated $237K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1992 holding.
  • Rockefeller Capital Management first reported a position in Catalyst Pharmaceutical in Q4 2020 and has held it in 21 quarters since.
  • Rockefeller Capital Management's Catalyst Pharmaceutical position peaked at $693K in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.